These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 8997766)

  • 21. [Buprenorphine abuse: high dose intravenous administration of buprenorphine].
    Varescon I; Vidal-Trécan G; Nabet N; Boissonnas A
    Encephale; 2002; 28(5 Pt 1):397-402. PubMed ID: 12386540
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [HIV and drug users: current trends].
    Golz JH
    MMW Fortschr Med; 2005 Apr; 147 Spec No 1():60-2. PubMed ID: 16385879
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Key Extended Entry Program (KEEP): from the community side of the bridge.
    Fallon BM
    Mt Sinai J Med; 2001 Jan; 68(1):21-7. PubMed ID: 11135502
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Heroin addiction among young people: a new development in Sri Lanka.
    Mendis N
    Bull Narc; 1985; 37(2-3):25-9. PubMed ID: 3878170
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rehabilitation of heroin and cocaine abusers managed in a Nigerian psychiatric hospital.
    Lawal RA; Adelekan ML; Ohaeri JU; Orija OB
    East Afr Med J; 1998 Feb; 75(2):107-12. PubMed ID: 9640835
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of qigong therapy in the detoxification of heroin addicts.
    Li M; Chen K; Mo Z
    Altern Ther Health Med; 2002; 8(1):50-4, 56-9. PubMed ID: 11795622
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Does maintenance treatment reduce the mortality rate of opioid addicts?].
    Scherbaum N; Specka M; Hauptmann G; Gastpar M
    Fortschr Neurol Psychiatr; 2002 Sep; 70(9):455-61. PubMed ID: 12215918
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High-frequency users of detoxification: who are they?
    Amodeo M; Lundgren L; Chassler D; Witas J
    Subst Use Misuse; 2008; 43(7):839-49. PubMed ID: 18570019
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prospective randomised comparative study of the effect of buprenorphine, methadone and heroin on the course of pregnancy, birthweight of newborns, early postpartum adaptation and course of the neonatal abstinence syndrome (NAS) in women followed up in the outpatient department.
    Binder T; Vavrinková B
    Neuro Endocrinol Lett; 2008 Feb; 29(1):80-6. PubMed ID: 18283247
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An integration of three approaches to addiction and methadone maintenance treatment: the self-medication hypothesis, the disease model and social criticism.
    Gelkopf M; Levitt S; Bleich A
    Isr J Psychiatry Relat Sci; 2002; 39(2):140-51. PubMed ID: 12227229
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Development of skin diseases in intravenous drug dependent patients treated with heroin substitution].
    Conrad C; Steffen T; Gutzwiller F
    Praxis (Bern 1994); 2000 Nov; 89(46):1899-906. PubMed ID: 11111408
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Benefits of retention in methadone maintenance and chronic medical conditions as risk factors for premature death among older heroin addicts.
    Fareed A; Casarella J; Amar R; Vayalapalli S; Drexler K
    J Psychiatr Pract; 2009 May; 15(3):227-34. PubMed ID: 19461397
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison between heroin and heroin-cocaine polyabusers: a psychopathological study.
    Bandettini Di Poggio A; Fornai F; Paparelli A; Pacini M; Perugi G; Maremmani I
    Ann N Y Acad Sci; 2006 Aug; 1074():438-45. PubMed ID: 17105942
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Two years follow-up of a heroin users cohort treated with high dosage buprenorphine. Results of the SPESUB study (pharmacoepidemiologic follow-up of general practice Subutex)].
    Duburcq A; Charpak Y; Blin P; Madec L
    Rev Epidemiol Sante Publique; 2000 Aug; 48(4):363-73. PubMed ID: 11011303
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Neuroleptic therapy of comorbid narcotic dependent patients in ambulatory methadone maintenance].
    Unglaub W; Kandel M; Zenner D; Wodarz N; Klein H
    Psychiatr Prax; 2003 May; 30 Suppl 2():S121-4. PubMed ID: 14509056
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Determinants of methadone treatment assignment among heroin addicts on first admission to public treatment centres in Italy.
    Bargagli AM; Schifano P; Davoli M; Faggiano F; Perucci CA;
    Drug Alcohol Depend; 2005 Aug; 79(2):191-9. PubMed ID: 16002028
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Are there new methods in therapy of drug dependence?].
    Täschner KL
    Z Arztl Fortbild (Jena); 1996 Jun; 90(4):315-20. PubMed ID: 8928531
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Flunitrazepam consumption among heroin addicts admitted for in-patient detoxification.
    San L; Tato J; Torrens M; Castillo C; Farré M; Camí J
    Drug Alcohol Depend; 1993 May; 32(3):281-6. PubMed ID: 8102333
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A six country survey of the content and structure of heroin treatment programmes using methadone.
    Gossop M; Grant M
    Br J Addict; 1991 Sep; 86(9):1151-60. PubMed ID: 1932887
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Inpatient withdrawal treatment of heroin dependence with neuroleptics--an approach to addicts].
    Presslich O; Schanda H; Hermann P
    Psychiatr Prax; 1983 Mar; 10(2):60-3. PubMed ID: 6134297
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.